Barry Meisenberg, M.D., medical director

Barry Meisenberg, M.D., medical director

On April 15, 2009, the New York Times discussed the rising cost of cancer medications and the impact this can have on the patients that rely on these medications to save their life.

Now, months later, prescription drugs – and those benefitting from them – are positioned squarely in the national spotlight as the health care reform debate continues across America.

According to Times’ reporter Andrew Pollack, “Pills and capsules are the new wave in cancer treatment, expected to account for 25 percent of all cancer medicines in a few years, up from less than 10 percent now.”

But how can we keep these medications affordable to those that truly need them?

Barry Meisenberg, M.D., medical director of the AAMC DeCesaris Cancer Institute, recently joined WYPR 88.1 FM, Baltimore’s National Public Radio to discuss health care reform and what it may mean to the thousands of Maryland residents living with cancer.  And he brought along a special guest – one of his own patients.  Listen here.

Post your comment